
Questions this month have been answered by:R. Wayne Whitted, MD., MPH, OBGYN.net Editorial Advisor
Questions this month have been answered by:R. Wayne Whitted, MD., MPH, OBGYN.net Editorial Advisor
If your patient is in an at-risk group according to the guidelines of the US Preventive Services Task Force, she should be referred for genetic counseling and be considered for testing.
The latest in medical products for obstetrics and gynecology.
Clomiphene is still the first choice to treat infertility and the gold standard for women with PCOS, argues this expert. He critiques research that suggests metformin is superior and discusses the reason two key trials yielded such starkly different results.
Two important studies have addressed this question. A closer look at each will help clinicians make an informed decision that's in each patient's best interest.
Now that laparoscopy during pregnancy is no longer considered too dangerous, should you remove a mass this way-and if so, when?
Now that laparoscopy during pregnancy is no longer considered too dangerous, should you remove a mass this way-and if so, when?
It goes without saying that expedient recognition of a rare condition, in and of itself, does not necessarily guarantee a favorable outcome. In situations where a physician exercises questionable judgment and the outcome is less than favorable, however, the door is open for second-guessers and an increased potential for litigation.
Women who undergo hysterectomy are much more likely to require subsequent surgery for stress urinary incontinence (SUI).
In 1994 and 2004 the FDA and the EPA set upper limits on fish consumption by pregnant and lactating women and children.
Coverage of 36th AAGL Congress November 2007, Washington, DC
Coverage of 36th AAGL Congress November 2007, Washington, DC
Coverage of 36th AAGL Congress November 2007, Washington, DC
Coverage of 36th AAGL Congress November 2007, Washington, DC
Coverage of 36th AAGL Congress November 2007, Washington, DC
Coverage of 36th AAGL Congress November 2007, Washington, DC
Coverage of 36th AAGL Congress November 2007, Washington, DC
Coverage of 36th AAGL Congress November 2007, Washington, DC
Coverage of 36th AAGL Congress November 2007, Washington, DC
Coverage of 36th AAGL Congress November 2007, Washington, DC
Coverage of 36th AAGL Congress November 2007, Washington, DC
Coverage of 36th AAGL Congress November 2007, Washington, DC
Coverage of 36th AAGL Congress November 2007, Washington, DC
Coverage of 36th AAGL Congress November 2007, Washington, DC
Coverage of 36th AAGL Congress November 2007, Washington, DC
Coverage of 36th AAGL Congress November 2007, Washington, DC
To investigate the accuracy of Osteoporosis Self-assessment Tool for Asians (OSTA) in identifying the risk of osteoporosis in postmenopausal women.
This month's questions answered by:Harvey S. Marchbein, MD, Chairman,OBGYN.net Osteoporosis Editorial Advisory Board
Questions this month have been answered by:Maria Luisa Bianchi, MD, Italy, OBGYN.net Osteoporosis Editorial Advisor
Questions this month have been answered by:Maria Luisa Bianchi, MD, Italy, OBGYN.net Osteoporosis Editorial Advisor